Acumen Pharmaceuticals (ABOS) Total Debt (2023 - 2026)
Acumen Pharmaceuticals (ABOS) posted Total Debt of $31.0 million for Q1 2026, little changed sequentially from $31.2 million in Q4 2025, and up 5.14% YoY from $29.5 million in Q1 2025.
Acumen Pharmaceuticals (ABOS) Total Debt (2023 - 2026) Analysis & Trends
Acumen Pharmaceuticals has reported Total Debt for 4 years, with the latest figure at $31.0 million in Q1 2026.
- Quarterly Total Debt rose 5.14% year-over-year to $31.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.0 million (up 5.14% YoY) and the FY2025 annual result came in at $31.2 million, up 5.92% from the prior year.
- Total Debt was little changed at $31.0 million in Q1 2026 per ABOS's latest filing, from $31.2 million in the prior quarter.
- Over five years, Total Debt peaked at $31.2 million in Q4 2025 and troughed at $29.4 million in Q2 2024.
- A 4-year average of $30.1 million and a median of $29.9 million in 2023 frame the typical range for Total Debt.
- The widest YoY moves for Total Debt: up 5.92% in 2025, down 2.25% in 2025.
- Over 4 years, Total Debt stood at $29.9 million in 2023, then retreated by 1.6% to $29.4 million in 2024, then gained by 5.92% to $31.2 million in 2025, then decreased by 0.37% to $31.0 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $31.0 million, $31.2 million, and $30.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | Acumen Pharmaceuticals | 226.87 Mn | 226.87 Mn | - | 31.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.57 Mn |
| Mar 31, 2026 | 31.05 Mn |
| Dec 31, 2025 | 31.16 Mn |
| Sep 30, 2025 | 30.65 Mn |
| Jun 30, 2025 | 29.88 Mn |
| Mar 31, 2025 | 29.53 Mn |
| Dec 31, 2024 | 29.42 Mn |
| Sep 30, 2024 | 29.67 Mn |
| Jun 30, 2024 | 29.38 Mn |
| Mar 31, 2024 | 30.21 Mn |
| Dec 31, 2023 | 29.90 Mn |